product summary
Loading...
company name :
R&D Systems
product type :
antibody
product name :
Afamin Antibody [Alexa Fluor Plus 488]
catalog :
NBP3-00101AFP488
quantity :
0.1 ml
price :
369 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
ELISA
more info or order :
product information
brand :
Novus
master code :
NBP3-00101AFP488
SKU :
NBP3-00101AFP488
product name :
Afamin Antibody [Alexa Fluor Plus 488]
sizes available :
0.1 ml
description :
The Afamin Antibody [Alexa Fluor Plus 488] from NBP3-00101AFP488 is a 6.7e-05 antibody to . This antibody reacts with human.
target :
Afamin
category :
Primary Antibodies
buffer :
50mM Sodium Borate
clonality :
Polyclonal
conjugate :
Alexa Fluor Plus 488
dilution :
ELISA
host :
Rabbit
immunogen :
Produced in rabbits immunized with purified, recombinant Human Afamin (Uniprot#: P43652; Met1-Asn599).
isotype :
IgG
purity :
Antigen and protein A Affinity-purified
species :
Human
gene symbol :
AFM
applications :
ELISA
USD :
369 USD
alt names :
afamin, ALB2alpha-Alb, ALBAalpha-albumin, ALF, Alpha-Alb, Alpha-albumin, MGC125338, MGC125339
storage :
Store at 4C in the dark.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Afamin Antibody [Alexa Fluor Plus 405] | NBP3-00101AFP405
- Afamin Antibody [Alexa Fluor® 750] | NBP3-00101AF750
- Leukotriene A4 Hydrolase/LTA4H Antibody (455) [DyLight 550] | NBP2-89375R
- Afamin Antibody [Alexa Fluor® 647] | NBP3-00101AF647
- Leukotriene A4 Hydrolase/LTA4H Antibody (457) [Alexa Fluor® 647] | NBP2-89376AF647
questions and comments
